Rituximab Reduces Specific Antibody Titres in Childhood-Onset Idiopathic Nephrotic Syndrome (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0635; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Surveillance of specific antibody titres following Rituximab, ideally when in remission on minimal immunosuppression, should be considered in INS patients, with booster vaccine doses as needed. Table 1: Effect of time, Rituximab courses, and time from Rituximab on antibody titres"
Clinical • Glomerulonephritis • Hepatitis B • Hepatology • Herpes Zoster • Infectious Disease • Inflammation • Measles • Nephrology • Pneumococcal Infections • Renal Disease • Varicella Zoster
|
|
Liangjian Lu; Chang-Yien Chan; Li Ling Quek; Sharon Teo; Mya Than; Yew Weng Perry Lau; Kar Hui Ng; Hui Kim Yap
|